SEC Filings
Press Releases
September 2, 2010 Herbert A. Fritsche, Ph.D., former M.D. Anderson Cancer Center Professor and Scientist, joinsHealth Discovery Corporation as Senior Vice President and Chief Science Officer
September 1, 2010 Health Discovery Corporation Announces Strategic Partnership with Adaptive, Inc.
August 26, 2010 Shareholder Letter
May 21, 2010 SVM Technology Wins Worldwide Marketing Challenge in Active Learning Competition
May 17, 2010 Health Discovery Corporation Receives Prestigious MICO Award From MDB Captial Group LLC
May 10, 2010 Health Discovery Corporation Appoints Maher Albitar M.D., Former Medical Director of Hematology and Oncology and Chief of Research and Development at Quest Diagnostics, Chief Medical Officer
May 7, 2010 Health Discovery Corporation Announces Suite by Large Shareholder Seeking Declaratory Judgment Regarding Termination Date of Warrants Held by Shareholder
March 17, 2010 Health Discovery Corporation and Smart Personalized Medicine Form Agreement for Developing Laboratory Tests for Breast Cancer Therapy Selection with Quest Diagnostics
March 3, 2010 Health Discovery Corporation applauds American Caner Society's Decision Against the use of PSA for Routine Prostate Cancer Screening
February 26, 2010 Health Discovery Corporation Placed in the Top 1% of the "Best and Brightest" Companies by MDB Capital for its Game-Changing Technology - HDC Receives Notice of Issuance from the USPT for New US Patent No 7,676,442
February 25, 2010 Dr. Nitesh Chawla from the University of Notre Dame joins Health Discovery Corporation Science Advisory Board
February 24, 2010 Health Discovery Corporation Announces Changes in Board of Directors
February 24, 2010 Health Discovery Corporation's Executives to Present at "Personalized Medicine Partnerships" Conference This Morning
February 23, 2010 SVM Capital Announces Successful Risk-Adjusted, 14-month Performance
February 22, 2010 Health Discovery Corporation Responds to Tabloid "News"
February 18, 2010 Health Discovery Corporation Selected as "Best & Brightest" Small Cap Company by MDB Capital Group and Expands Patent Portfolio
February 16, 2010 Health Discovery Corporation Introducing the World's First Mobile Phone App for Melanoma and Other Skin Cancers Using SVM-Based Image Analysis
February 9, 2010 Health Discovery Corporation Inks Deal for Final Validation of a New Molecular Diagnostic Test for Colon Cancer
February 5, 2010 Health Discovery Corporation Partners with Major New York City Pancreatic Cancer Center to Develop a New Molecular Diagnostic Test for the Early Detection of Pancreatic Cancer
February 3, 2010 Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment
February 2, 2010 Health Discovery Corporation's Test May Help Curb the Second-Leading Cause of Cancer Death.
November 30, 2009 Health Discovery Corporation Appoints Tom Gallagher, former Wall Street Attorney & a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies
November 4, 2009 Health Discovery Corporation Offers an Intra-Quarterly Update, Commentary on the Value of Prostate Cancer Screening and Invites the American Cancer Society to Act Immediately
October 19, 2009 Health Discovery Corporation Announces Addtional Issued Patents and Notices of Allowances to Its Intellectual Property Portfolio
October 9, 2009 Health Discovery Corporation Hires The Dilenschneider Group, a New Yourk City IR/PR Firm
September 24, 2009 Health Discovery Corporation's Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize the Field of Molecular Diagnostics
September 18, 2009 Former Deputy FDA Commissioner John Norris Appointed Chief Operating Officer at Health Discovery Corporation
July 14, 2009 Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient
May 4, 2009 Health Discovery Corporation Names R. Scott Tobin as President and General Counsel
February 5, 2009 Health Discovery Corporation Licenses Biomarkers for Noninvasive Urine-Based Prostate Cancer Test to Quest Diagnostics
February 5, 2009 Health Discovery Corporation Licenses New Prostate Cancer Test to Abbott
January 13, 2009 Clarient Launches Gene Expression Test for Prostate Cancer
